Top Markets
Coin of the day
ShockWave Medical, Inc. ShockWave Medical, Inc.

ShockWave Medical, Inc.

SWAV
Rank in Stocks #1816
ShockWave Medical, Inc. is a medical technology firm that specializes in the... ShockWave Medical, Inc. is a medical technology firm that specializes in the development and global commercialization of intravascular lithotripsy (IVL) systems. This innovative approach is designed to treat calcified plaque in individuals affected by peripheral vascular, coronary vascular, and heart valve conditions. The company's product offerings include the M5 catheter for addressing above-the-knee peripheral artery disease, the C2 catheter specifically for coronary artery disease, and the S4 catheter, which targets below-the-knee peripheral artery disease. ShockWave Medical serves a professional clientele, including interventional cardiologists, vascular surgeons, and interventional radiologists, leveraging both direct sales teams and distribution partners. The organization was founded in 2009 and is based in Santa Clara, California.
Share Price
$334.75
Last synced: 2024-05-30
Market Cap
$12.46B
Change (1 day)
-0.02%
Change (1 year)
0.00%
Country
US
Trade ShockWave Medical, Inc. (SWAV)

Category

Revenue for ShockWave Medical, Inc. (SWAV)
Revenue in Mar 2024 TTM: $787.97M
According to ShockWave Medical, Inc. latest financial reports the company's current revenue (TTM) is $787.97M. In 2022 the company made a revenue of $489.73M an increase over the revenue in the year 2021 that was $237.15M. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for ShockWave Medical, Inc. from 2017 to 2026
Revenue at the end of each year
Year Revenue Change
2026 (TTM) $787.97M 7.91%
2023 $730.23M 49.11%
2022 $489.73M 106.51%
2021 $237.15M 249.83%
2020 $67.79M 57.92%
2019 $42.93M 250.05%
2018 $12.26M 613.38%
2017 $1.72M 0.00%
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
$46.59B 5,812.03%
US
$25.84B 3,178.94%
US
$35.48B 4,403.22%
IE
$21.00B 2,564.57%
US
- -
DE